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To the Editor: We read with interest the discussions
of Dr. Hou regarding the best ways to improve organ
donations [1]. As usually happens in this field, most strat-
egies are cited to imply that they did not achieve signifi- Bone mass evolution after renal
cant improvements. Rather surprising, the Spanish expe-
rience is not even considered, despite the fact that Spain transplantation
is the only large country (40 million citizens) in the world
with a sustained and progressive increase of cadaveric
To the Editor: Now that tailoring immunosuppressionorgan donation rates during the last decade.
Since the National Transplant Organization was estab- is possible, efforts have concentrated on the prevention
lished in 1989, together with a national network of in- of post-transplant complications, including bone demin-
hospital, specifically trained, part-time, dedicated, and eralization. In this context, the recent study by Westeel et
strongly motivated physicians in charge of organ pro- al suggests that cyclosporine-steroid immunosuppression
curement [2], Spain has increased its organ donations may prevent post-transplant osteopenia [1].
from 14 to 33.6 organ donors per million people in 1999, Unfortunately, this conclusion is not convincing. It rests
a 142% increase [3]. This organ donor rate is by far the only upon data collected between 3 and 24 months post-
highest in the world (the United States has 21.8 per transplantation. When the first post-transplant months
million people, Canada has 13.8, and the mean of the are included, all published studies agree that cyclosporine-
other European countries is 14.3), which has also re- steroid–based immunosuppression is consistently associ-
sulted in the highest transplant rates of cadaveric kidney, ated with bone loss [2, 3]. We have confirmed this conclu-
liver, heart, and lungs [4]. There was no change in legisla- sion in 44 unselected graft recipients (Fig. 1).
tion during this period and, as in most European coun-
The bone loss between 3 and 24 months post-trans-tries, permission from the family is always obtained be-
plantation that can be anticipated from the results offore donation.
previous studies averages 1.5% [2, 3]. The results ofThe number of renal transplants rose from 1039 in
Westeel et al that were collected during this interval are1989 to 2023 ten years later, 99% cadaveric (50.6 per
thus of borderline significance when the precision errormillion people versus 29.9 in the United States), a sig-
of the methods used to evaluate bone mass is considerednificant and sustained increase that, at least in our opin-
(0.4 and 6 2 to 4% for the dual energy x-ray absorpti-ion, deserves a reference in reviews from authors of
ometry and the quantitative computed tomography [4],possible methods to expand the donor pool. The “Span-
respectively).ish Model” results from the efforts of many to overcome
Finally, these authors’ conclusions are limited by pa-obstacles such as untrained or under trained staff, un-
tient selection, specifically excluding osteopenic post-identified donors, and the reluctance to approach griev-
ing family members. menopausal women. Indeed, the independent effect on
bone mass when the normal ovarian cycle is resumed in
Rafael Matesanz and Blanca Miranda pre-menopausal women, as well as the prescription of
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potential osteogenic drugs (such as statins or thiazides)
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The clinician concerned with the fate of the patientE-mail: rafmatesanz@yahoo.es
throughout the first post-transplant year will find mini-
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Fig. 1. Bone mineral density measured by
dual energy x-ray absorptiometry at 12 months
post-transplantation. It is expressed as the per-
centage of the value obtained at the time of
transplantation. It falls significantly in all the
evaluated sites. Immunosuppression includes
cyclosporine, steroids (maintenance dose of
7.5 mg/day after 120 days) and either myco-
phenolate mofetil or azathioprine. (*P , 0.05,
**P , 0.01, ***P , 0.001).
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morning urine, collected 2 hours after the first urination.edited by Blake GM, Wahner HW, Fogelman I, London, Martin
Dunitz Ltd., 1999, pp 45–72 With creatinine adjustment, the measured protein con-
centrations are comparable to those yielded by 24-hour
urine collections. Postrenal proteinuria can be excluded
by measuring a2-macroglobulin [3].Selectivity of proteinuria Selectivity can then be calculated solely by the ratio
of IgG to transferrin in urine. This ratio compares wellcan be estimated reliably with the laborious selectivity index. In 167 samples, we
compared the selectivity index with the urinary IgG/from samples of second- transferrin ratio and found a high degree of correspon-
dence (Table 1). Of the samples, 97% (125 of 129) weremorning urine correctly classified as unselective by measuring only the
transferrin/IgG ratio in urine. There was some overlap
between selective and unselective patterns when the se-To the Editor: In a recent issue of Kidney Interna-
lectivity index was between 0.2 and 0.3, while samplestional, Bazzi et al showed that the ratio of IgG and
with a selectivity index of less than 0.2 always presentedtransferrin clearances, the selectivity index, provides val-
with a selective pattern.uable information in the management of the renal pa-
The selectivity index, however, will provide more accu-tient [1]. It requires, however, the measurement of trans-
rate results in the presence of prerenal or postrenal pro-ferrin and IgG in serum as well as in urine.
tein variabilities. IgG, for instance, can be elevated inThis is in contrast to the convenient concept of measur-
serum because of monoclonal or polyclonal components,
while a postrenal IgG increase may accompany a urinary
tract infection.Ó 2001 by the International Society of Nephrology
